van Zanten Sander Veldhuyzen, van der Knoop Bloeme
Division of Gastroenterology, University of Alberta, Zeidler Ledcor Centre, Edmonton, Alberta, Canada.
Eur J Gastroenterol Hepatol. 2008 Jun;20(6):489-91. doi: 10.1097/MEG.0b013e3282f427c8.
Whether it is a requirement to continue with anti-secretory therapy following anti-Helicobacter therapy in H. pylori positive gastric ulcers is an important question. As gastric ulcers tend to heal more slowly than duodenal ulcers, may be asymptomatic or only causing mild symptoms and success at curing H. pylori with current fist line therapies is 80% at best, clinicians will likely err on the side of caution and continue acid suppressive therapy to ensure healing of gastric ulcers. This is certainly recommended when dealing with bleeding ulcers.
对于幽门螺杆菌阳性胃溃疡患者,在抗幽门螺杆菌治疗后是否需要继续进行抗分泌治疗是一个重要问题。由于胃溃疡往往比十二指肠溃疡愈合得更慢,可能无症状或仅引起轻微症状,且目前一线治疗治愈幽门螺杆菌的成功率最高仅为80%,临床医生可能会谨慎行事,继续进行抑酸治疗以确保胃溃疡愈合。在处理出血性溃疡时,这当然是推荐的做法。